SCHEMBL6569742

SCHEMBL6569742

O=C(NN=Cc1cc(O)ccc1O)c1ccc(O)cc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.79
MAOA P21397 1/20 0.73
MAOB P27338 1/20 0.73
GCGR P47871 2/20 0.66
MEN1 O00255 4/20 0.63
RAB9A P51151 4/20 0.63
KMT2A Q03164 4/20 0.63
KDM4E B2RXH2 3/20 0.63
PSMD14 O00487 1/20 0.63
LMNA P02545 1/20 0.63
POLB P06746 1/20 0.63
MMP2 P08253 1/20 0.63
HTT P42858 1/20 0.63
BLM P54132 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
SIRT1 Q96EB6 1/20 0.63
NPC1 O15118 3/20 0.62
MGAM O43451 2/20 0.61
MITF O75030 2/20 0.59
L3MBTL1 Q9Y468 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6569739 1.00 KDM1A (0.79) KDM1AMAOAMAOBGCGRMEN1
SCHEMBL6751411 0.91 KDM1A (0.85) KDM1AMAOAMAOBGCGRMEN1
SCHEMBL6751409 0.91 KDM1A (0.85) KDM1AMAOAMAOBGCGRMEN1
SCHEMBL12387714 0.91 KDM1A (0.67) KDM1AMAOAMAOBGCGRMEN1
SCHEMBL6568355 0.91 KDM1A (0.69) KDM1AMAOAMAOBGCGRMEN1
SCHEMBL6568358 0.91 KDM1A (0.69) KDM1AMAOAMAOBGCGRMEN1
SCHEMBL19283330 0.88 KDM1A (1.00) KDM1AMAOAMAOBGCGRMEN1
SCHEMBL19283336 0.88 KMT2A (0.76) KDM1AMAOAMAOBGCGRMEN1
SCHEMBL19283338 0.88 KMT2A (0.76) KDM1AMAOAMAOBGCGRMEN1
SCHEMBL14285643 0.88 KDM1A (1.00) KDM1AMAOAMAOBGCGRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110963-A1 Novel hydrazones ARPIDA AG (CH) 2004-06-10 US claimed
US-20040110963-A1 Novel hydrazones ARPIDA AG (CH) 2004-06-10 US disclosed
EP-1404644-A2 NOVEL HYDRAZONES Arpida AG, (CH) 2004-04-07 EP disclosed
WO-2002070464-A2 HYDRAZONES AND THEIR THERAPEUTIC USE ARPIDA AG (CH) 2002-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110963-A1 Novel hydrazones H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HK1, MPO KDM1A 2684/4885MAOA 1268/4885MAOB 1704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.